Literature DB >> 6360777

Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.

D L Sarson, P G Kopelman, H S Besterman, T R Pilkington, S R Bloom.   

Abstract

Studies were carried out in 32 obese patients and 30 normal-weight control subjects to ascertain the response of glucose-dependent insulinotropic polypeptide (GIP) and insulin to (1) oral and intravenous glucose (10 obese and 10 control subjects), (2) oral fat and intravenous glucose (eight obese and six control subjects) and (3) mixed test meal (14 obese and 14 control subjects). Basal mean insulin was higher in the obese (99 pmol/l) than in the control group (40 pmol/l), but fasting blood glucose and GIP were not significantly different from normal. The total integrated response of insulin in obese subjects after oral glucose was 54.1 versus 33.3 nmol . l-1 . h-1 in control subjects; glucose and GIP responses were similar in both groups. After intravenous glucose the integrated insulin response was 8.8 in the obese versus 5.0 nmol . l-1 . h-1 in control subjects; GIP was unaffected by intravenous glucose and glucose levels were similar. Following oral fat and intravenous glucose, insulin secretion was again abnormal in the obese, 24.5 versus 7.3 nmol . l-1 . h-1 in controls, but GIP responses were normal. However, the control subjects became hypoglycaemic after this test: blood glucose 2.8 mmol/l at 150 min compared with 4.6 mmol/l in the obese group. The insulin response to a mixed meal was also abnormal in obesity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6360777     DOI: 10.1007/bf00282515

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

2.  A glycoside-hydrolase inhibitor in treatment of dumping syndrome.

Authors:  J C McLoughlin; K D Buchanan; M J Alam
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

Review 3.  Candidate hormones of the gut. XV. Insulin-releasing factors of the gastrointestinal mucosa (Incretin).

Authors:  M Creutzfeldt
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

4.  Hormonal profile and forearm metabolism in human obesity.

Authors:  D Rabinowitz
Journal:  Am J Clin Nutr       Date:  1968-12       Impact factor: 7.045

5.  Plasma insulin and growth hormone levels in obesity and diabetes.

Authors:  R S Yalow; S M Glick; J Roth; S A Berson
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

6.  Effect of diet composition on the hyperinsulinemia of obesity.

Authors:  N Grey; D M Kipnis
Journal:  N Engl J Med       Date:  1971-10-07       Impact factor: 91.245

7.  Insulin secretion in obesity.

Authors:  R A Kreisberg; B R Boshell; J DiPlacido; R F Roddam
Journal:  N Engl J Med       Date:  1967-02-09       Impact factor: 91.245

8.  Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.

Authors:  K B Lauritsen; A J Moody; K C Christensen; S Lindkaer Jensen
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

9.  A radioimmunoassay of gastric inhibitory polypeptide in human plasma.

Authors:  D L Sarson; M G Bryant; S R Bloom
Journal:  J Endocrinol       Date:  1980-06       Impact factor: 4.286

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  6 in total

1.  Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects.

Authors:  L G Trahair; C S Marathe; S Standfield; C K Rayner; C Feinle-Bisset; M Horowitz; K L Jones
Journal:  Int J Obes (Lond)       Date:  2016-12-06       Impact factor: 5.095

2.  GIP and the metabolic response to carbohydrate and fat.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

3.  The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  I R Jones; D R Owens; S Luzio; S Williams; T M Hayes
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

4.  Pancreatic islet hormone response to oral glucose in morbidly obese patients.

Authors:  K R Sirinek; T M O'Dorisio; B Howe; A S McFee
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

5.  Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.

Authors:  R Ebert; W Creutzfeldt
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

6.  Metabolic and Hormonal Alterations with Diacylglycerol and Low Glycemic Index Starch during Canine Weight Loss.

Authors:  Yuka Mitsuhashi; Daisuke Nagaoka; Karen E Bigley; Tomoshige Umeda; Kazuya Otsuji; John E Bauer
Journal:  ISRN Vet Sci       Date:  2012-12-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.